Leukocyte CD11b and CD62L expression in response to interstitial inflammation in CAPD patients

Peritoneal Dialysis International

Volumn 24, Issue 1, 2004, Pages 28-36

  Dadfar, Elham ^a   Lundahl, Joachim ^a   Fernvik, Eva ^a   Nopp, Anna ^a   Hylander, Britta ^a   Jacobson, Stefan H ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adhesion molecules CD11b and CD62L; Inflammation; Interstitium; Leukocytes

Indexed keywords

BUFFER; CD11B ANTIGEN; INTERLEUKIN 8; L SELECTIN; LEUKOCYTE ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BULLOUS SKIN DISEASE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HEMODIALYSIS PATIENT; HUMAN; IMMUNOHISTOCHEMISTRY; INTERSTITIUM; LEUKOCYTE COUNT; LEUKOCYTE MOTILITY; MALE; MONOCYTE; PERITONEUM EXUDATE; PRIORITY JOURNAL; SKIN INFLAMMATION;

EID: 3042736737     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080402400103     Document Type: Article

References (28)

1. Bloembergen BE, Port FK. Epidemiological perspective on infections in chronic dialysis patients. Adv Ren Replace Ther 1996; 3:201-7.
2. Hoen B, Paul-Dauphin A, Heston D, Kessler M. EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol 1998; 9:869-76.
3. Mailloux L, Bellucci A, Wilkes B, Napolitano B, Mossey R, Lesser M, et al. Mortality in dialysis patients: analysis of the cause of death. Am J Kidney Dis 1991; 18: 326-35.
4. Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 2000; 58:1758-64.
5. Powe NR, Jaar B, Furth SL, Hermann J, Briggs W. Septicemia in dialysis patients: incidence, risk factors and prognosis. Kidney Int 1999; 55:1081-90.
6. Sarnak MJ, Jaber BL. Pulmonary infectious mortality among patients with end-stage renal disease. Chest 2001; 120:1883-7.
7. Cohen G, Haag-Weber M, Hörl WH. Immune dysfunction in uremia. Kidney Int Suppl 1997; 62:79-82.
8. Haag-Weber M, Hörl WH. Dysfunction of polymorphonuclear leukocytes in uremia. Semin Nephrol 1996; 16: 192-201.
9. Ward RA. Phagocytic cell function as an index of biocompatibility. Nephrol Dial Transplant 1994; 9(Suppl 2):46-56.
10. Rapoport J, Hausmann MJ, Chaimovitz C. The peritoneal immune system and continuous ambulatory peritoneal dialysis. Nephron 1999; 81:375-80.
11. Jutila MA. Leukocyte traffic to sites of inflammation. APMIS 1992; 100:191-201.
12. Worthylake RA, Burridge K. Leukocyte transendothelial migration: orchestrating the underlying molecular machinery. Curr Opin Cell Biol 2001; 13:569-77.
13. Thylén P, Lundahl J, Fernvik E, Grönneberg R, Halldén G, Jacobson SH. Impaired monocyte CD11b expression in interstitial inflammation in hemodialysis patients. Kidney Int 2000; 57:2099-106.
14. Arnaout MA, Todd RF, Dana N, Melamed J, Schlossman SF, Colten HR. Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3-binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mo1). J Clin Invest 1983; 72:171-9.
15. Gresham HD, Graham IL, Anderson DC, Brown EJ. Leukocyte adhesion-deficient neutrophils fail to amplify phagocytic function in response to stimulation. J Clin Invest 1991; 88:588-97.
16. Fallman M, Andersson R, Andersson T. Signaling properties of CR3 (CD11b andCD18) and CR1 (CD35) in relation to phagocytosis of complement-opsonized particles. J Immunol 1993; 151:330-8.
17. Scheja A, Forsgren A. A skin chamber technique for leukocyte migration studies; description and reproducibility. Acta Pathol Microbiol Immunol Scand [C] 1985; 93:25-30.
18. Sengeloev H, Follin P, Kjeldsen L, Lollike K, Dahlgren C, Borregaard N. Mobilization of granules and secretory vesicles during in vivo exudation of human neutrophils. J Immunol 1995; 154:4157-65.
19. Yamada S, Mayadas TN, Yuan F, Wagner DD, Hynes RO, Melder RJ, et al. Rolling in P-selectin-deficient mouse is reduced but not eliminated in the dorsal skin. Blood 1995; 86:3487-92.
20. Jacobson SH, Thylén P, Fernvik E, Halldén G, Grönneberg R, Lundahl J. Hemodialysis activated granulocytes at the site of interstitial inflammation. Am J Kidney Dis 2002; 39:854-61.
21. Haag-Weber M, Mai B, Hörl WH. Impaired cellular host defense in peritoneal dialysis by two granulocyte inhibitory proteins. Nephrol Dial Transplant 1994; 9:1769-73.
22. Cohen G, Haag-Weber M, Mai B, Deicher R, Hörl WH. Effect of immunoglobulin light chains from hemodialysis and continuous ambulatory peritoneal dialysis patients on polymorphonuclear leukocyte functions. J Am Soc Nephrol 1995; 6:1592-9.
23. Cohen G, Rudnicki M, Hörl WH. A peptide isolated from a patient on continuous ambulatory peritoneal dialysis has homology to ubiquitin and inhibits the chemotactic response of polymorphonuclear leukocytes. Miner Electrolyte Metab 1997; 23:210-13.
24. Goldstein CS, Bomalaski JS, Zurier RB, Neilson EG, Douglas SD. Analysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis. Kidney Int 1984; 26:733-40.
25. Davies SJ, Suassuna J, Ogg CS, Cameron JS. Activation of immunocompetent cells in the peritoneum of patients treated with CAPD. Kidney Int 1989; 36:661-8.
26. McGregor SJ, Topley N, Jörres A, Speekenbrink AB, Gordon A, Gahl GM, et al. Longitudinal evaluation of peritoneal macrophage function and activation during CAPD: maturity, cytokine synthesis and arachidonic acid metabolism. Kidney Int 1996; 49:525-33.
27. Bos HJ, Struijk DG, Tuk CW, de Weld JC, Helerhorst TJM, Hoefsmit ECM, et al. Peritoneal dialysis induces a local sterile inflammatory state and the mesothelial cells in the affluent are related to the bacterial peritonitis incidence. Nephron 1991; 59:508-9.
28. Carcamo C, Fernandez-Castro M, Selgas R, Jimenez C, Molina S, Vara F. Long-term continuous ambulatory peritoneal dialysis reduces the expression of CD11b, CD14 and CD64 on peritoneal macrophages. Perit Dial Int 1996; 16:582-9.